July 2017 P&T Updates
|
|
|
- MargaretMargaret Byrd
- 10 months ago
- Views:
Transcription
1 July 2017 P&T Updates Commercial Triple Tier 4th Tier Applicable Traditional Prior Auth Alternatives ALUNBRIG 3 2 DUPIXENT Pharmacy tablets per day, 30 day One-week auth for QL of 3 syringes per 28 Remainder of the 6 month auth duration, QL of 2 syringes per 28 Then, 2/28 Elidel*, topical prednisone, prednisolone EUCRISA 3 No 2 No - prednisolone, prednisone ISENTRESS HD 2 No 2 No 2 tablets per day - RILUZOLE 1 No 1 No No - none RYDAPT 3 2 STIVARGA 3 2 AML: 56 capsules per 21 SM: 112 capsules per tablets per 28 Systemic Mastocytosis: imatinib 1 No 1 No No - - No 1 tablet per day Amitiza, Linzess - XERMELO 3 2 ZEJULA tablets per day, 28 day 3 tablets per day, 30 day octreotide, Somatuline Depot*
2 CHIP Tier Prior Auth ALUNBRIG 2 DUPIXENT Pharmacy 2 6 tablets per day, 30 day One-week auth for QL of 3 syringes per 28 Remainder of the 6 month auth duration, QL of 2 syringes per 28 Alternatives Elidel*, prednisone, prednisolone Then, 2/28 topical EUCRISA 2 No - prednisolone, prednisone ISENTRESS HD 2 No 2 tablets per day - RILUZOLE 2 No No - none AML: 56 capsules per 21 RYDAPT 2 SM: 112 capsules per 28 Systemic Mastocytosis: imatinib STIVARGA 2 84 tablets per 28-2 No No tablet per day Amitiza, Linzess XERMELO 2 3 tablets per day, 28 day octreotide, Somatuline Depot* ZEJULA 2 3 tablets per day, 30 day
3 GHP Family GHP Family Tier Prior Auth Alternative(s) ALUNBRIG Brand 6 tablets daily Xalkori*, Alcensa*, Zykadia* ATOMOXETINE Generic No 10 mg, 100 mg, 40 mg, 60 mg, 80 mg one capsule daily, 18 mg two capsules daily, 25 mg three capsules daily DUPIXENT Brand 2 syringes per 28 EUCRISA Brand No - Methylphenidate, Methylphenidate ER, Amphetamine Salt Combo, Amphetamine- Dextroamphetamine, Amphetamine- Dextroamphetamine ER, Guanfacine ER tacroliumus ointment, Elidel* tacroliumus ointment, Elidel* FOSRENOL PACKETS Brand No No - Fosrenol Tablets, Renagel ISENTRESS HD Brand No two tablets daily Isentress Tablet, Isentress Chewable Tablet LINZESS Brand No - Amitiza* OCTREOTIDE Generic No No - e RILUZOLE Generic No No - e RYDAPT Brand AML - 56 capsules per 21, SM capsules per 28 imatinib* STIVARGA Brand 84 tablets per 28 e Generic No No - Elidel* one tablet daily Amitiza*, Linzess* XERMELO Brand three tablets daily octrotide ZEJULA Brand 3 tablets daily Beginning August 15th, any prescription for greater than a 7 day supply of opioids for anyone age 17 or younger will require prior authorization. Beginning September 15th, any prescription for a greater than 14 day supply of opioids for anyone age 18 and older will require prior authorization. Beginning September 15th, any high dose of opioids will require prior authorization. Beginning November 1, new opioid quantity limits will be effective. Please call for details.
4 Geisinger Gold $0 Deductible ALUNBRIG Specialty DUPIXENT Specialty EUCRISA Brand Preferred IMFINZI Specialty ISENTRESS HD Specialty RADICAVA Specialty RYDAPT Specialty Standard Prior Auth 6 tablets/day 8 ml in Alternative(s) clobetasol, halobetasol, clobetasol, halobetasol, Bavencio*, Keytruda*, Opdivo*, Tecentriq* No 2 tablets/day Isentress 2800 mls every capsules per 28 riluzole Imatinib Generic No - - alclometasone, clobetasol, desonide, diflorasone, fluocinolone, fluticasone, halobetasol, mometasone, XERMELO Specialty ZEJULA Specialty Amitiza, Linzess 3 tablets/day octreotide, Somatuline Depot 3 tablets/day
5 Marketplace Tier Prior Auth ALUNBRIG 5 DUPIXENT Pharmacy 5 6 tablets per day, 30 day One-week auth for QL of 3 syringes per 28 Remainder of the 6 month auth duration, QL of 2 syringes per 28 Alternatives Elidel*, topical prednisone, prednisolone Then, 2/28 EUCRISA 4 No - prednisolone, prednisone ISENTRESS HD 3 No 2 tablets per day - RILUZOLE 2 No No - none RYDAPT 5 AML: 56 capsules per 21 SM: 112 capsules per 28 Systemic Mastocytosis: imatinib STIVARGA 5 84 tablets per 28-2 No No tablet per day Amitiza, Linzess XERMELO 5 3 tablets per day, 28 day octreotide, Somatuline Depot* ZEJULA 5 3 tablets per day, 30 day
May 2017 P&T Updates
May 2017 P&T Updates Commercial Triple Tier 4th Tier Applicable Traditional Prior Auth Alternatives 6 ml per AMPYRA 3 2 2 tablets per day, 30 day BYDUREON 3 2 4 vials per 28 days 5 mcg pen: 1.2 ml per
March 2018 P & T Updates
March 2018 P & T Updates Commercial Triple Tier 4th Tier Applicable Traditional Prior Auth AURYXIA 3 2 12 tablets per BAXDELA TABLETS 3 2 2 tablets per Depending on your specific benefits and in which
Medication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018
Independent licensees of the Blue Cross and Blue Shield Association Medication Policy Manual Policy No: dru493 Topic: Dupixent, dupilumab Date of Origin: March 10, 2017 Committee Approval: March 10, 2017
Neighborhood Medicaid Formulary Changes: June 2017
Neighborhood Medicaid Formulary Changes: June 2017 The following changes to the Neighborhood Medicaid Formulary were recently approved by the Pharmacy and Therapeutics (P&T) Committee. All changes were
UnitedHealthcare Pharmacy Clinical Pharmacy Programs
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 2116-3 Program Prior Authorization/Medical Necessity Medications Dupixent (dupilumab) P&T Approval Date 1/2017, 5/2017, 7/2017
The safety and effectiveness of Dupixent in pediatric patients have not been established (1).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.30 Subject: Dupixent Page: 1 of 6 Last Review Date: June 22, 2017 Dupixent Description Dupixent (dupilumab)
The safety and effectiveness of Dupixent in pediatric patients have not been established (1).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.90.30 Subject: Dupixent Page: 1 of 6 Last Review Date: September 15, 2017 Dupixent Description Dupixent
CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 3Q17 July August
BRAND NAME Dupixent GENERIC NAME dupilumab MANUFACTURER Regeneron DATE OF APPROVAL March 28, 2017 PRODUCT LAUNCH DATE First week of April 2017 REVIEW TYPE Review type 1 (RT1): New Drug Review Full review
2015 Step Therapy Prior Authorization Medical Necessity Guidelines
Tufts Health Unify 2015 Step Therapy Prior Authorization Medical Necessity Guidelines Effective: 01/01/2015 Updated: 10/01/2015 Tufts Health Plan P.O. Box 9194 Watertown, MA 02471-9194 Phone: 855-393-3154
GA KS KY LA MD NJ NV NY TN TX WA Applicable X N/A N/A X N/A X X X X X X N/A N/A X *FHK- Florida Healthy Kids. ADHD Narcolepsy
Override(s) Prior Authorization ADHD Narcolepsy Approval Duration 1 year *Louisiana, Washington and Maryland Medicaid See State Specific Information Below Medications Atomoxetine: Strattera generic Clonidine
Quarterly pharmacy formulary change notice
Provider Bulletin June 2017 The formulary changes listed in the table below apply to all Anthem HealthKeepers Plus patients. These changes were reviewed and approved at the first quarter Pharmacy and Therapeutics
Pharmacy Medical Necessity Guidelines: CNS Stimulant Medications
Pharmacy Medical Necessity Guidelines: CNS Stimulant Medications Effective: June 1, 2017 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy
Oral Oncology Agents. August 2017 Update. SGLT-2 Category Update. Removal of Medical Foods
SUPPORTING OUR PROVIDER PARTNERS THROUGH COMMUNICATION AND COLLABORATION. DATE SEPTEMBER 2017 ISSUE 4 HELPFUL NUMBERS FOR PROVIDERS CVS: 1-888-512-8935 Primary: 004336 Secondary Commercial: 013089 Secondary
Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications
Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications Effective: January 1, 2018 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy
Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions
Alameda Alliance for Health FORMULARY UPDATE Effective: October 27, 2017. Drugs notated with an * have an undetermined implementation date Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee
2018 Medicare Part D Formulary Change
2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy
Reason for change. Recently approved. Recently approved. Recently approved. Recently approved. Recently updated. Recently approved.
2017 Formulary Change Notice Please note these changes to your 2017 List of Covered Drugs Drug name (medication) Rubraca Aprepitant Onivyde Oseltamivir Restasis Xiidra Daptomycin Selzentry Linzess Butalb/APAP/caff
Effective for all members on August 1, 2017
August 2017 Pharmacy Formulary Change Notice BlueChoice HealthPlan Medicaid is here to help you stay on top of your health care. We want to tell you about some upcoming changes to your Preferred Drug List
Dupixent (dupilumab)
Dupixent (dupilumab) Line(s) of Business: HMO; PPO; QUEST Integration Effective Date: TBD POLICY A. INDICATIONS The indications below including FDA-approved indications and compendial uses are considered
Central Nervous System Stimulants Drug Class Prior Authorization Protocol
Line of Business: Medi-Cal Effective Date: August 16, 2017 Revision Date: August 16, 2017 Central Nervous System Stimulants Drug Class Prior Authorization Protocol This policy has been developed through
UPDATE Ohana QUEST Integration Medicaid
UPDATE Ohana QUEST Integration Medicaid Preferred Drug List June 29, 2015 Dear Provider: At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes
Drug Formulary Update, January 2013
Drug Formulary Update, January 2013 Updates to the HealthPartners Drug Formularies are listed below. Updates for the Commercial Drug Formularies and the Minnesota Health Care Programs (Medicaid and Minnesota
The Medical Letter. on Drugs and Therapeutics
The Medical Letter publications are protected by US and international copyright laws. Forwarding, copying or any other distribution of this material is strictly prohibited. For further information call:
Stimulants. The psychostimulants, or more simply known as stimulants, are used primarily in treating attention-deficit/ Dosing Information
Adderall and Adderall-XR (amphetamine mixtures) Concerta (methylphenidate, controlled Dexedrine, Dexedrine Spansules (dextroamphetamine) Focalin (dexmethylphenidate) Metadate, Metadate-ER, and Metadate-CD
2017 Step Therapy (ST) Criteria
2017 Step Therapy (ST) Criteria Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a
PHARMACY AND THERAPEUTICS COMMITTEE August 2016
PHARMACY AND THERAPEUTICS COMMITTEE August 2016 A meeting of the Health Partners Pharmacy and Therapeutics (P&T) Committee was held on August 23, 2016. The following are the recommendations for the drugs
Pharmacy Benefit Determination Policy
Policy Subject: Atopic Dermatitis Agents Policy Number: SHS PBD18 Category: Policy Type: Medical Pharmacy Department: Pharmacy Product (check all that apply): Group HMO/POS Individual HMO/POS PPO ASO s:
2017 Medicare Part D Formulary Change
2017 Medicare Part D Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy restrictions
ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018
Step Therapy Requirements Effective April 1, 2018 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone
Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health
Big Lots Behavioral Health Prescribing Guidelines for Behavioral Health Prescribing for Behavioral Health This document was developed by Nationwide Children s Hospital in conjunction with Partners For
Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
Allergy Chlorpheniramine Tablet* Diphenhydramine Tablet* Diphenhydramine Liquid* Loratadine Tablet* Cetirizine Tablet* Loratadine 10mg ODT* Less than $10 Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*
Clinical Policy: CNS Stimulants Reference Number: CP.PMN.XX Effective Date: Last Review Date: Line of Business: Commercial, Medicaid
Clinical Policy: Reference Number: CP.PMN.XX Effective Date: 03.01.18 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy for important
Amitiza. Amitiza (lubiprostone) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.22 Subject: Amitiza Page: 1 of 5 Last Review Date: March 16, 2018 Amitiza Description Amitiza (lubiprostone)
BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES
BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES Blue Shield is committed to covering safe, effective and affordable medications, so we regularly review and update our drug formularies.
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.PMN.04 Effective Date: 11.15.17 Last Review Date: 05.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy for important
Behavioral Health. Behavioral Health. Prescribing Guidelines
Behavioral Health Behavioral Health Prescribing Guidelines Attention Deficit/Hyperactivity Disorder (ADHD) Start with a first line medication, either from the methylphenidate or dextroamphetamine-amphetamine
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand
Pharmacy Updates Summary
All of the following changes were reviewed and approved by the SFHP Pharmacy & Therapeutics (P&T) Committee on 04/15/2015 Effective date: 05/15/2015 Therapeutic Classes reviewed: Testosterone replacement
PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017
PHARMACY AND THERAPEUTICS COMMITTEE 4 th Quarter 2017 A meeting of the Health Partners Pharmacy and Therapeutics (P&T) Committee was held on September and December 2017. The following are the recommendations
High-Cost Drug Exclusions
PHARMACY SERVICES High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at
Topical Immunomodulators
Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Topical Immunomodulators Clinical Criteria Information Included in this Document Topical Immunomodulators Elidel and Protopic 0.03% Drugs
Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6
in Children under Age 6 Level 0 Conduct comprehensive assessment and provide psychoeducation about ADHD, including clearly defined treatment expectations. Consider co-morbid developmental language disorder,
2. Treatment of patients with metastatic, squamous NSCLC progressing after platinumbased
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.39 Subject: Gilotrif Page: 1 of 5 Last Review Date: September 15, 2017 Gilotrif Description Gilotrif
Children s Hospital Of Wisconsin
Children s Hospital Of Wisconsin Co-Management Guidelines To support collaborative care, we have developed guidelines for our community providers to utilize when referring to, and managing patients with,
Step Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG
Part D Pharmacy. An Independent Licensee of the Blue Cross Blue Shield Association ( )
Part D Pharmacy 1 An Independent Licensee of the Blue Cross Blue Shield Association 044507 (12-21-2017) New MA pharmacy partner We ve selected CVS Caremark to manage our part D pharmacy benefits Providence
ADHD Medications: Basics. David Benhayon MD, PhD
ADHD Medications: Basics David Benhayon MD, PhD Goals & Objectives Understand basic classes of stimulants and equivalents Be exposed to role of nonstimulant alternatives Discuss the role of therapy in
TN Cover Rx Tennessee CoverRx MAC Price Change List As of: 04/26/2018
1 Tennessee CoverRx List Run : 04/26/18 Dosage Form amiodarone HCl 200 MG TABLET ORAL 04/25/2018 0.16102 0.14405 11.8 hydralazine HCl 100 MG TABLET ORAL 04/25/2015 0.11390 0.10854 4.9 hydralazine HCl 25
Pharmacy benefit guide
FlexRx SM 5-Tier Pharmacy benefit guide 1 Welcome to FlexRx The NHP FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many common medications
Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children
Judges Reference Table for the Psychotropic Medication Utilization Parameters for Foster Children Stimulants for treatment of ADHD Preschool (Ages 3-5 years) Child (Ages 6-12 years) Adolescent (Ages 13-17
OVERVIEW FOOD AND DRUG ADMINISTRATION-APPROVED INDICATIONS
Pharmacy Medical Necessity Guidelines: Effective: September 18, 2017 Prior Authorization Required Type of Review Care Management Not Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit
Pharmacy and Therapeutics (P&T) Committee Provider Update
Pharmacy and Therapeutics (P&T) Committee Provider Update FIRST QUARTER 2017 P&T Committee Decisions effective March 1, 2017 Dear Healthcare Practitioner: The Presbyterian Health Plan, Inc., and Presbyterian
Methylphenidate also has an off-label indication for depression, although published trials are limited in size and duration (14).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.60.25 Yeah Subject: Methylphenidates Page: 1 of 5 Last Review Date: December 2, 2016 Methylphenidate
Dextroamphetamine vs ritalin
P ford residence southampton, ny Dextroamphetamine vs ritalin Photo by istock.com/ognianm What are prescription stimulants? 24-12-2016 Find a comprehensive guide to possible side effects including common
Conversion from focalin xr to vyvanse
Conversion from focalin xr to vyvanse The Borg System is 100 % Conversion from focalin xr to vyvanse Sep 3, 2007. The importance of the 'conversion' dosing listed above relates to those people who may
Oregon Health Plan prescription benefit updates
Oregon Health Plan prescription benefit updates EOCCO s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save
Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017
Pharmacy Program Updates: Quarterly Pharmacy Changes Effective July 1, 2017 DRUG LIST CHANGES Based on the availability of new prescription medications and Prime s National Pharmacy and Therapeutics Committee
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Enstilar, Sernivo, Taclonex) Reference Number: CP.CPA.255 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end
UnitedHealthcare Pharmacy Clinical Pharmacy Programs. Program Number 2017 P Prior Authorization/Notification CNS Stimulants
UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2017 P 1020-6 Program Prior Authorization/Notification CNS Stimulants Medication Adderall* (amphetamine-dextroamphetamine mixed salts),
AETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on February 1, 2017 Drug Name, Strength, Dosage Form IVERMECTIN 3 MG TABLET
Methylphenidate Dexmethylphenidate
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.60.25 Yeah Subject: Methylphenidates Page: 1 of 6 Last Review Date: September 15, 2017 Methylphenidate
NOTIFICATION OF FORMULARY CHANGES
NOTIFICATION OF CHANGES The following summary describes changes to the 2018 Presbyterian Senior Care (HMO)/(HMO-POS), Presbyterian MediCare PPO and formularies. The formulary may change at any time. You
2017 Formulary Changes Year to Date
2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or
Adderall to focalin conversion
Search Search Adderall to focalin conversion Methylphenidate is generally well tolerated. The most commonly observed adverse effects with a frequency greater than placebo include appetite loss, dry mouth.
Clinical Policy: CNS Stimulants Reference Number: CP.PMN.92 Effective Date: Last Review Date: Line of Business: Commercial, Medicaid
Clinical Policy: Reference Number: CP.PMN.92 Effective Date: 03.01.18 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Revision Log See Important Reminder at the end of this policy for important
1. With regard to efficacy, the following conclusions were made: Acute coronary syndrome (ACS):
DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL I. UNIFORM FORMULARY REVIEW PROCESS Under 10 United States Code 1074g, as implemented
QUANTITY LIMIT CRITERIA
DRUG CLASS (ADHD) AGENTS BRAND NAME (generic) QUANTITY LIMIT CRITERIA ATTENTION DEFICIT HYPERACTIVITY DISORDER ADDERALL (amphetamine mixture) ADDERALL XR (amphetamine extended-release mixture) ADZENYS
Coverage Period: 01/01/ /31/2018 Coverage for: Individual and/or Family Plan: Healthy Rewards HSA
This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanrx.com/member
2015 Medicare Step Therapy Criteria. Last Modified: 12/31/2014 Last Submitted to CMS: 10/29/2014
2015 Medicare Step Therapy Criteria Last Modified: 12/31/2014 Last Submitted to CMS: 10/29/2014 1 Table of Contents AMITIZA, LINZESS... 3 ANTIDEPRESSANTS - Viibryd / Pexeva / Pristiq / Desvenlafaxine...
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES
PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Generic Additions These generic drugs recently became available in the marketplace. When these generic drugs became available, we began covering them at the
2014 Medicare Step Therapy Criteria. Last Modified: Last Submitted to CMS:
2014 Medicare Step Therapy Criteria Last Modified: 09.30.2014 Last Submitted to CMS: 09.02.2014 1 Table of Contents AMITIZA, LINZESS... 3 ANTIDEPRESSANTS - Viibryd / Pexeva / Pristiq / Desvenlafaxine...
IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members
IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance
MARYLAND MEDICAL ASSISTANCE PROGRAM Pharmacy Transmittal No Maryland Pharmacy Assistance Program Transmittal No. 39 February 22, 1999
1 PT17-99 MARYLAND MEDICAL ASSISTANCE PROGRAM Pharmacy Transmittal No. 160 Maryland Pharmacy Assistance Program Transmittal No. 39 February 22, 1999 TO: FROM: NOTE: RE: Physicians Pharmacists Martin P.
Attention Deficit Hyperactivity Disorder or ADHD
Diagnosis/Disease/Illness Si usted desea esta información en español, por favor pídasela a su enfermero o doctor. Name of Child: Date: Attention Deficit Hyperactivity Disorder or ADHD What it is: Children
Coverage Period: Coverage for: Plans: This is only a summary of your GatorCare pharmacy benefits. Coinsurance: you your Dependent Copayment: you
This is only a summary of your GatorCare pharmacy benefits. If you would like detail about your coverage and costs, you can get the complete terms in the policy or plan document at gatorcare.magellanrx.com/member
Extended release adderall
Extended release adderall The Borg System is 100 % Extended release adderall Use Adderall XR (dextroamphetamine and amphetamine extended-release capsules (adderall XR)) as you were told by your doctor.
JULY 2017 ADDITIONS. NP Thyroid 120mg NP Thyroid 15mg JUNE 2017 CHANGES
APRIL 2017 Ivermectin, Pin-X and Reeses (Pyrantel Pamoate) Selzentry 25mg and 75mg tablets Linzess 72 mcg capsule-with QLL Levalbuterol Tartrate Inhal Aerosol (Generic Xopenex HFA) with ST & QLL Jentadueto
Adderall dosage for adults chart
P ford residence southampton, ny Adderall dosage for adults chart First let me start off by saying that Im specifically talking about "D-Amphetamine Salt Combo" which as far as I can tell IS Generic Adderall.
Ritalin mg equal to adderall
P ford residence southampton, ny Ritalin mg equal to adderall Snorting Ritalin will make you go through a pill every ten mi a, then 2 every 10. Try or Ritalin it got me good for three hours and wasn't
Formulary (Drug List)
Formulary (Drug List) PacificSource Community Solutions This list was updated on /5/07 Please Read: This document contains information about the drugs we cover on this plan. For a complete, up-to-date
Peach State Health Plan routinely reviews the medications available on the Preferred Drug
Effective date: December 27, 2016 Peach State Health Plan Preferred Drug List (PDL) Updates Q4 2016 Peach State Health Plan routinely reviews the medications available on the Preferred Drug List (PDL).
Velphoro (sucroferric oxyhydroxide)
STRENGTH DOSAGE FORM ROUTE GPID 500mg chewable tablet oral 36003 MANUFACTURER Fresenius Medical Care North America INDICATION(S) For the control of serum phosphorus levels in patients with chronic kidney
Step Therapy Requirements
An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet
Product List Finished Dosage Forms (FDF) B2B Business
Product List 2017 Finished Dosage Forms (FDF) B2B Business Anaesthetics Dermatology Lidocaine Lidocaine and Prilocaine Dexmedetomidine Hydrochloride Anti-Infectives Amoxicillin Trihydrate and Potassium
Section I contains changes to the Highmark Select/Choice Formulary.
June 2007 2 nd Quarter Update: Highmark Drug Formulary Enclosed is the 2 nd Quarter 2007 update to the Highmark Drug Formulary and pharmaceutical management procedures. The Formulary and pharmaceutical
Step Therapy Approval Criteria
Effective Date: 01/01/2018 This document contains Step Therapy Approval Criteria for the following medications: 1. Colcrys (colchicine) 2. Dovonex (calcipotriene) 3. Enbrel (etanercept) 4. Humira (adalimumab)
Allergies and Asthma 5/21/2013. Objectives. Allergic Rhinitis (AR): Risk Factor for ASTHMA. Rhinitis and Asthma
Allergies and Asthma Presented By: Dr. Fadwa Gillanders, Pharm.D Clinical Pharmacy Specialist May 2013 Objectives Understand the relationship between asthma and allergic rhinitis Understand what is going
amphetamines Will methylphenidate show as amphetamines
Will methylphenidate show as amphetamines The Borg System is 100 Will methylphenidate show as amphetamines How Long Does Methylphenidate Stay in Your panel for amphetamines, methylphenidate will show how
Prescription benefit updates Individual/small group
Prescription benefit updates Individual/small group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps
UPDATE WellCare s South Carolina
March 26, 2015 UPDATE WellCare s South Carolina Preferred Drug List Dear Provider: At the March 05, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will
UPDATE Georgia Medicaid
March 26, 2015 UPDATE Georgia Medicaid Preferred Drug List Dear Provider: At the March 05, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will be made
12.1 DRUGS ACTING ON THE EAR
12.1 DRUGS ACTING ON THE EAR Anti-inflammatory/anti-infective preparations These preparations usually contain a corticosteroid either alone or with an antibacterial agent. Betamethasone 0.1% ear, eye,
Prescription benefit updates Large group
Prescription benefit updates Large group Moda Health s prescription program is a pharmacy benefit that offers members a choice of safe and effective medication treatments. The program also helps you save
Commonwealth Care Alliance (Medicare-Medicaid Plan) One Care Plan
2018 List of Covered Drugs (Formulary) Commonwealth Care Alliance (Medicare-Medicaid Plan) One Care Plan 30 Winter Street Boston, MA 02108 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS
Dilantin Retail Price
Dilantin Retail Price when to order phenytoin level dilantin capsule package insert dilantin 250 mg what is dilantin facies dilantin 100 mg extended release cost of dilantin dilantin 100mg price generic
2017 Step Therapy Criteria
FRESENIUS TOTAL HEALTH 2017 Step Therapy Updated 07/01/2017. For more recent information or other questions, please contact Fresenius Total Health Customer Service at 1-855-598-6774 / TTY 1-844-209-9094.
MEDICAL ASSISTANCE BULLETIN
ISSUE DATE January 22, 2013 SUBJECT EFFECTIVE DATE January 15, 2013 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Drug List (PDL) Update January 15, 2013 Pharmacy Services Vincent D. Gordon, Deputy
Individual Market Schedule of Benefits
Individual Market Schedule of Benefits Deductible and Out-of-Pocket Maximum Plan Deductible Individual Family $150 per Member $300 per Family $8,000 per Member $16,000 per Family Out-of-Pocket Maximum
ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP
ATOPIC DERMATITIS: PATHOPHYSIOLOGY AND PHARMACOLOGY OF MANAGEMENT PEGGY VERNON, RN, MA, C-PNP, DCNP, FAANP Disclosures Promotional Speaker for Pfizer, Inc. Any unlabeled/unapproved uses of drugs or products
Conversion table methylphenidate to vyvanse
P ford residence southampton, ny Conversion table methylphenidate to vyvanse Lisdexamfetamine dimesylate is converted to dextoamphetamine and L- lysine, which is of ADDERALL XR (10, 20, or 30 mg), Vyvanse